Tennessee HB1741 amends state laws to ensure non-opioid pain medications are not disadvantaged in insurance coverage.
Tennessee HB1741 amends various state laws to ensure that non-opioid medications for pain treatment are not disadvantaged in insurance coverage. The bill requires insurers to maintain a preferred drug list (PDL) that does not disadvantage non-opioid medications approved by the FDA for nine months or longer. This applies to drugs covered under insurance policies and those provided under contracts between insurers and pharmacy benefits managers. The act aims to ensure fair coverage for non-opioid medications relative to opioid drugs.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.